bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding bluebird bio, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 1.39K | 0 | −1.39K (−100.0%) |
| Value | $6.89K | $0 | −$6.89K (−100.0%) |
New holders (0)
Institutions that held bluebird bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (3)
Institutions that held bluebird bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Russell Investments Group, Ltd. | 1,386 | $6.89K |
| Barclays PLC | 1 | $4 |
| IFP Advisors, Inc | 7 | $3 |